Is this you? Create Your Porfile
Avatar

Armin Walser

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Armin Walser is active.

Explore More

Publication

Featured researches published by Armin Walser.

Archive | 2002

Acylated indanyl amines and their use as pharmaceuticals

Hartmut Strobel; Paulus Wohlfart; Alena Safarova; Armin Walser; Teri Suzuki; Karl Schonafinger; Ramalinga M. Dharanipragada

Archive | 2002

Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments

Lothar Schwink; Siegfried Stengelin; Matthias Gossel; Armin Walser; Gerard Rosse

Archive | 1998

Indole derivatives as inhibitors or factor Xa

Elisabeth Defossa; Uwe Heinelt; Otmar Klingler; Gerhard Zoller; Fahad Al-Obeidi; Armin Walser; Peter Wildgoose; Hans Matter

Archive | 2002

4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical

Paulus Wohlfart; Teri Suzuki; Ramalinga M. Dharanipragada; Alena Safarova; Armin Walser; Hartmut Strobel

Archive | 2003

Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect

Lothar Schwink; Siegfried Stengelin; Matthias Gossel; Thomas Boehme; Gerhard Hessler; Gerard Rosse; Armin Walser

Archive | 2001

Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them

Fahad Al-Obeidi; Armin Walser; Peter Wildgoose

Archive | 2003

Substituted diaryl heterocycles, method for the production and use thereof as medicaments

Lothar Schwink; Siegfried Stengelis; Matthias Gossel; Thomas Boehme; Gerhard Hessler; Gerard Rosse; Armin Walser

Archive | 1999

Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)

Elisabeth Defossa; Uwe Heinelt; Otmar Klingler; Gerhard Zoller; Hans Matter; Fahad Al-Obeidi; Armin Walser; Peter Wildgoose

Archive | 1999

New aminoacid residue substituted benzimidazole derivative I(kappa)B-kinase inhibitors, useful for treating NF(kappa)B-related disorders e.g. rheumatoid arthritis, asthma, Alzheimer's disease and cancer

Olaf Ritzeler; Hans Ulrich Stilz; Bernhard Neises; William Jerome Bock; Armin Walser; Gary A. Flynn

Archive | 2000

N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them

Otmar Klingler; Gerhard Zoller; Elisabeth Defossa; Fahad Al-Obeidi; Armin Walser; James Ostrem

Explore More

Collaboration

Dive into the Armin Walser's collaboration.

Top Co-Authors
Avatar

Gerard Rosse

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Lothar Schwink

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Matthias Gossel

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Siegfried Stengelin

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Alena Safarova

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gerhard Hessler

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hartmut Strobel

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Teri Suzuki

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Thomas Boehme

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Paulus Wohlfart

University of Mainz

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge